Brevan Howard Capital Management LP Acquires Shares of 11,328 Cabot Co. (NYSE:CBT)

Brevan Howard Capital Management LP bought a new stake in shares of Cabot Co. (NYSE:CBTFree Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 11,328 shares of the specialty chemicals company’s stock, valued at approximately $1,034,000.

Other large investors also recently modified their holdings of the company. Norges Bank acquired a new position in Cabot in the fourth quarter valued at about $37,961,000. Copeland Capital Management LLC increased its holdings in Cabot by 21.6% in the 4th quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company’s stock valued at $69,521,000 after buying an additional 135,119 shares during the period. American Century Companies Inc. raised its position in shares of Cabot by 8.5% in the 4th quarter. American Century Companies Inc. now owns 1,323,347 shares of the specialty chemicals company’s stock valued at $120,835,000 after buying an additional 103,380 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Cabot by 27.1% during the 4th quarter. JPMorgan Chase & Co. now owns 451,513 shares of the specialty chemicals company’s stock worth $41,228,000 after acquiring an additional 96,179 shares during the period. Finally, Northern Trust Corp boosted its position in shares of Cabot by 12.4% during the 4th quarter. Northern Trust Corp now owns 794,477 shares of the specialty chemicals company’s stock worth $72,544,000 after acquiring an additional 87,881 shares in the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Stock Performance

NYSE CBT opened at $73.07 on Thursday. The firm’s fifty day moving average price is $80.45 and its two-hundred day moving average price is $91.79. The stock has a market cap of $3.96 billion, a PE ratio of 9.70, a PEG ratio of 0.74 and a beta of 0.91. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. Cabot Co. has a fifty-two week low of $71.64 and a fifty-two week high of $117.46.

Cabot (NYSE:CBTGet Free Report) last issued its quarterly earnings data on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share for the quarter, topping analysts’ consensus estimates of $1.86 by $0.04. The business had revenue of $936.00 million for the quarter, compared to analyst estimates of $1.02 billion. Cabot had a return on equity of 26.79% and a net margin of 10.60%. Cabot’s quarterly revenue was down 8.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.78 EPS. On average, equities analysts expect that Cabot Co. will post 7.57 EPS for the current fiscal year.

Cabot Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be given a dividend of $0.45 per share. The ex-dividend date is Friday, May 30th. This is an increase from Cabot’s previous quarterly dividend of $0.43. This represents a $1.80 annualized dividend and a yield of 2.46%. Cabot’s dividend payout ratio (DPR) is currently 22.84%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on CBT shares. JPMorgan Chase & Co. cut their target price on Cabot from $105.00 to $85.00 and set an “underweight” rating for the company in a research note on Friday, February 21st. StockNews.com downgraded Cabot from a “buy” rating to a “hold” rating in a research report on Wednesday. Finally, UBS Group decreased their target price on Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a research report on Monday, April 7th.

Read Our Latest Research Report on CBT

Cabot Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.